Skip to main content
logo
4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
12.19
+0.54 (4.64%)
At close: Aug 14, 2026, 4:00 PM EDT
12.19
0.00 (0.00%)
After-hours: Aug 14, 2026, 4:20 PM EDT

4D Molecular Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-179.18-140.11-160.87-100.84-107.49-71.32
Depreciation & Amortization
8.137.636.715.753.883.02
Loss (Gain) From Sale of Assets
0.04-----
Loss (Gain) From Sale of Investments
-4.43-4.73-7.18-1.241.060.72
Stock-Based Compensation
20.4122.0226.1819.7517.2113.89
Other Operating Activities
0.05-0.050.040.16-00.09
Change in Accounts Receivable
----0.051.44
Change in Accounts Payable
1.936.770.870.9-1.642.29
Change in Unearned Revenue
2.03-0.210.07-0.72-3.13-14.72
Change in Other Net Operating Assets
-5.06-0.39-0.40.453.39-4.54
Operating Cash Flow
-156.07-109.08-134.59-75.79-86.69-69.13
Operating Cash Flow Growth
------
Capital Expenditures
0.11-0.54-3.79-2.77-11.54-9.11
Investment in Securities
-16.74-92.44-298.65118.49-5.51-163.57
Investing Cash Flow
-16.64-92.97-302.44115.72-17.05-172.68
Issuance of Common Stock
146.66112.96337.25156.833.55118.09
Other Financing Activities
-----0.47-
Financing Cash Flow
165.92112.96337.25156.833.09118.09
Net Cash Flow
-6.79-89.1-99.77196.76-100.65-123.73
Free Cash Flow
-155.97-109.62-138.37-78.56-98.22-78.24
Free Cash Flow Growth
------
Free Cash Flow Margin
-169.51%-128.65%-373975.68%-379.11%-3139.05%-433.77%
Free Cash Flow Per Share
-2.41-1.89-2.56-2.01-3.04-2.82
Levered Free Cash Flow
-89.17-54.15-82.29-46.48-59.7-41
Unlevered Free Cash Flow
-89.17-54.15-82.29-46.48-59.7-41
Change in Working Capital
-1.16.170.540.63-1.34-15.53
SEC Filings: 10-K · 10-Q